GOVX
NASDAQ
$0.99
Geovax Labs Inc (GOVX)
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $10 (+915.23%)
Market Cap
$6.29M
FCF 5Y CAGR
+35.51%
Price Chart
Valuation
Market Cap$6.29M
Forward P/E9.65
P/S9.09
P/B14.14
Profitability
Total Revenue (TTM)$852K
Gross Profit (TTM)-$16M
EBITDA-$21M
Operating Margin-2523%
EPS-$18.17
Growth & Risk
Revenue 5Y CAGR-6.89%
FCF 5Y CAGR+35.51%
Sharpe Ratio-1.46